Casi Pharmaceuticals Inc (CASI)
2.31 -0.12 (-4.94%) 12:49 ET [NASDAQ]
2.30 x 9 2.37 x 5
Realtime by (Cboe BZX)
2.30 x 9 2.37 x 5
Realtime - - (-) -
for Wed, Mar 19th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,738 | -14,545 | -4,559 | -8,101 | -8,216 |
| Depreciation Amortization | 17 | 21 | 38 | 70 | 74 |
| Accounts receivable | 669 | 1,263 | 818 | 537 | 593 |
| Accounts payable and accrued liabilities | -102 | 52 | -898 | -618 | -1,528 |
| Other Working Capital | 401 | 1,293 | -352 | -276 | -2,594 |
| Other Operating Activity | 1,478 | 9,705 | 680 | 3,428 | 1,459 |
| Operating Cash Flow | $-3,276 | $-2,212 | $-4,272 | $-4,960 | $-10,213 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 27 | 0 | 7,503 |
| PPE Investments | -43 | -48 | 51 | -2 | -3 |
| Investing Cash Flow | $-43 | $-48 | $77 | $-2 | $7,500 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 10,000 | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | -758 | -8,554 | -7,708 |
| Common Stock Issued | 10,850 | 2 | 1,312 | 13,094 | N/A |
| Other Financing Activity | -448 | -773 | -165 | -1,005 | -10 |
| Financing Cash Flow | $10,401 | $9,229 | $390 | $3,535 | $-7,718 |
| Beginning Cash Position | 8,049 | 1,081 | 4,886 | 6,312 | 16,743 |
| End Cash Position | 15,132 | 8,049 | 1,081 | 4,886 | 6,312 |
| Net Cash Flow | $7,082 | $6,969 | $-3,805 | $-1,426 | $-10,431 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,276 | -2,212 | -4,272 | -4,960 | -10,213 |
| Capital Expenditure | -43 | -48 | -6 | -4 | -3 |
| Free Cash Flow | -3,319 | -2,261 | -4,278 | -4,963 | -10,216 |